Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
British Journal of Cancer
|
July 17, 1999
Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans
T B Christensen, J Marqversen, F Engbaek, et al.
Ugeskrift for Laeger
|
May 11, 1999
[Isotope technique for identification of the sentinel node in malignant melanoma]
A I Eigtved, M L Krag, K K Dahlstrøm, et al.
Ugeskrift for Laeger
|
May 11, 1999
[Sentinel node diagnostics in malignant melanoma]
A I Eigtved, M L Krag, K K Dahlstrøm, et al.
British Journal of Cancer
|
July 17, 1999
125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
T B Christensen, F Engbaek, J Marqversen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
O S Nielsen, P Reichardt, T B Christensen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
P Reichardt, O S Nielsen, S Bauer, et al.
European Journal of Biochemistry
|
April 1, 1992
Isolation and characterization of two biologically active O-glycosylated forms of human parathyroid hormone produced in Saccharomyces cerevisiae. Identification of a new motif for O-glycosylation
O K Olstad, S Reppe, O S Gabrielsen, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
British Journal of Cancer
|
July 17, 1999
Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans
T B Christensen, J Marqversen, F Engbaek, et al.
Ugeskrift for Laeger
|
May 11, 1999
[Isotope technique for identification of the sentinel node in malignant melanoma]
A I Eigtved, M L Krag, K K Dahlstrøm, et al.
Ugeskrift for Laeger
|
May 11, 1999
[Sentinel node diagnostics in malignant melanoma]
A I Eigtved, M L Krag, K K Dahlstrøm, et al.
British Journal of Cancer
|
July 17, 1999
125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
T B Christensen, F Engbaek, J Marqversen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
O S Nielsen, P Reichardt, T B Christensen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
P Reichardt, O S Nielsen, S Bauer, et al.
European Journal of Biochemistry
|
April 1, 1992
Isolation and characterization of two biologically active O-glycosylated forms of human parathyroid hormone produced in Saccharomyces cerevisiae. Identification of a new motif for O-glycosylation
O K Olstad, S Reppe, O S Gabrielsen, et al.
Page
of 5